Peter Tattersall, Ph.D.

Approaches and Lessons Learned for Analytical Method Transfers to Manufacturing Sites at Various Stages of Development
Tuesday, July 31, 2018
Analytical method transfers to external testing sites are required by health authorities to ensure both quality of clinical materials provided to patients, and effective testing during registrational stability studies. read more
A Fast, Generic and Systematic Approach to vHPLC Impurity Method Development
Wednesday, December 01, 2010
Gathering analytical data on impurities is important for early stage pharmaceutical development. In early development (phase I / II) the drug substance (DS) synthesis route, the solid state form and formulation are not final,... read more
Monitoring GMP Compliance in an Analytical R&D Laboratory by use of a Peer-Led Program
Friday, January 01, 2010
During pharmaceutical development, the performance of pharmaceutical products intended for investigational purposes are often unknown and/or not optimized, however, one element critical to the safety and efficacy of ... read more

Articles by Peter Tattersall, Ph.D.